Quadrant Capital Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.91K | Sell |
538
-1,211
| -69% | -$7.25K | ﹤0.01% | 2455 |
|
|
2025
Q4 | $12.2K | Buy |
1,749
+964
| +123% | +$6.34K | ﹤0.01% | 2153 |
|
|
2025
Q3 | $5.06K | Buy |
+785
| New | +$5.37K | ﹤0.01% | 2319 |
|
|
2025
Q2 | – | Sell |
-4,085
| Closed | -$26.4K | – | 1494 |
|
|
2025
Q1 | $26.4K | Sell |
4,085
-48
| -1% | -$345 | ﹤0.01% | 1948 |
|
|
2024
Q4 | $33.3K | Sell |
4,133
-293
| -7% | -$2.42K | ﹤0.01% | 1643 |
|
|
2024
Q3 | $36.1K | Buy |
4,426
+312
| +8% | +$2.06K | ﹤0.01% | 1622 |
|
|
2024
Q2 | $28.7K | Buy |
4,114
+523
| +15% | +$3.96K | ﹤0.01% | 1696 |
|
|
2024
Q1 | $38.1K | Sell |
3,591
-62
| -2% | -$542 | ﹤0.01% | 1536 |
|
|
2023
Q4 | $29.3K | Sell |
3,653
-2
| -0.1% | -$15 | ﹤0.01% | 1646 |
|
|
2023
Q3 | $30K | Hold |
3,655
| – | – | ﹤0.01% | 1515 |
|
|
2023
Q2 | $29.2K | Sell |
3,655
-384
| -10% | -$2.83K | ﹤0.01% | 1518 |
|
|
2023
Q1 | $32.7K | Hold |
4,039
| – | – | ﹤0.01% | 1455 |
|
|
2022
Q4 | $25.4K | Sell |
4,039
-1,812
| -31% | -$12.7K | ﹤0.01% | 1539 |
|
|
2022
Q3 | $40K | Buy |
5,851
+4,726
| +420% | +$32.8K | 0.01% | 1157 |
|
|
2022
Q2 | $9K | Sell |
1,125
-1,863
| -62% | -$26K | ﹤0.01% | 1698 |
|
|
2022
Q1 | $68K | Sell |
2,988
-953
| -24% | -$23.3K | 0.01% | 812 |
|
|
2021
Q4 | $109K | Buy |
3,941
+1,005
| +34% | +$26.9K | 0.01% | 629 |
|
|
2021
Q3 | $82K | Buy |
2,936
+175
| +6% | +$4.96K | 0.01% | 685 |
|
|
2021
Q2 | $81K | Buy |
2,761
+490
| +22% | +$14.8K | 0.01% | 676 |
|
|
2021
Q1 | $72K | Buy |
2,271
+192
| +9% | +$5.63K | 0.01% | 688 |
|
|
2020
Q4 | $43K | Buy |
2,079
+652
| +46% | +$12.2K | 0.01% | 796 |
|
|
2020
Q3 | $22K | Buy |
1,427
+95
| +7% | +$1.64K | ﹤0.01% | 914 |
|
|
2020
Q2 | $24K | Sell |
1,332
-2,957
| -69% | -$52.1K | 0.01% | 983 |
|
|
2020
Q1 | $65K | Buy |
4,289
+160
| +4% | +$3.86K | 0.01% | 752 |
|
|
2019
Q4 | $122K | Sell |
4,129
-5,002
| -55% | -$130K | 0.01% | 867 |
|
|
2019
Q3 | $196K | Hold |
9,131
| – | – | 0.03% | 606 |
|
|
2019
Q2 | $228K | Buy |
9,131
+1,497
| +20% | +$35.5K | 0.04% | 504 |
|
|
2019
Q1 | $186K | Buy |
7,634
+1,684
| +28% | +$40.2K | 0.03% | 526 |
|
|
2018
Q4 | $105K | Buy |
5,950
+1,211
| +26% | +$28.8K | 0.03% | 581 |
|
|
2018
Q3 | $118K | Hold |
4,739
| – | – | 0.03% | 357 |
|
|
2018
Q2 | $108K | Buy |
4,739
+182
| +4% | +$3.76K | 0.04% | 376 |
|
|
2018
Q1 | $71K | Hold |
4,557
| – | – | 0.03% | 520 |
|
|
2017
Q4 | $92K | Hold |
4,557
| – | – | 0.04% | 424 |
|
|
2017
Q3 | $63K | Hold |
4,557
| – | – | 0.03% | 529 |
|
|
2017
Q2 | $77K | Buy |
4,557
+4,206
| +1,198% | +$50.4K | 0.03% | 411 |
|
|
2017
Q1 | $3K | Buy |
351
+318
| +964% | +$4.38K | ﹤0.01% | 1475 |
|
|
2016
Q4 | $0 | Buy |
33
+7
| +27% | +$128 | ﹤0.01% | 2004 |
|
|
2016
Q3 | $0 | Sell |
26
-33
| -56% | -$854 | ﹤0.01% | 1999 |
|
|
2016
Q2 | $0 | Sell |
59
-106
| -64% | -$3K | ﹤0.01% | 1981 |
|
|
2016
Q1 | $3K | Buy |
165
+73
| +79% | +$5.4K | ﹤0.01% | 1268 |
|
|
2015
Q4 | $6K | Buy |
92
+61
| +197% | +$6.85K | ﹤0.01% | 969 |
|
|
2015
Q3 | $5K | Sell |
31
-2
| -6% | -$466 | ﹤0.01% | 804 |
|
|
2015
Q2 | $7K | Buy |
+33
| New | +$7.32K | ﹤0.01% | 769 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Quadrant Capital Group's BHC Position: Q1 2026 in Review
Quadrant Capital Group reduced its Bausch Health (BHC) stake by 69% in Q1 2026, selling an estimated $7.25K and leaving 538 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.
Quadrant Capital Group first reported a position in BHC in Q2 2015 and has held it in 43 quarters since. The position peaked at $228K in Q2 2019. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Quadrant Capital Group held 538 shares of Bausch Health worth $2.91K as of Q1 2026.
- Quadrant Capital Group sold 1,211 Bausch Health shares in Q1 2026, an estimated $7.25K.
- Bausch Health made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2455 holding.
- Quadrant Capital Group first reported a position in Bausch Health in Q2 2015 and has held it in 43 quarters since.
- Quadrant Capital Group's Bausch Health position peaked at $228K in Q2 2019.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.